Table 3 Sixty-day outcomes.
Outcomes | All patients |
---|---|
(n = 632) | |
60-day composite outcome | 268 (42.4) |
Death from any cause (as events before adverse drug reaction occurrence) | 78 (12.3) |
TB-related death | 58 (9.2) |
Non-TB-related deatha | 20 (3.2) |
Adverse drug reactions | 190 (30.1) |
Gastrointestinal dysfunctionb | 68 (10.8) |
Hepatitis | 55 (8.7) |
Rash | 31 (4.9) |
Fever | 11 (1.7) |
Acute kidney injury | 7 (1.1) |
Thrombocytopenia | 5 (0.8) |
Pneumonia | 3 (0.5) |
Visual disturbance | 3 (0.5) |
CNS disorder | 2 (0.3) |
Peripheral neuropathy | 2 (0.3) |
Othersc | 3 (0.5) |
All-cause death within 60 daysd | 94 (14.9) |
TB-related | 68 (10.8) |
Non-TB-related | 26 (4.1) |